Detalhe da pesquisa
1.
Monitoring quality and coverage of harm reduction services for people who use drugs: a consensus study.
Harm Reduct J
; 14(1): 19, 2017 04 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-28431584
2.
Across the spectrum of legality: The market activities of influencers specialized in steroids and other performance and image enhancing drugs.
Int J Drug Policy
; 123: 104246, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37979285
3.
Change is possible: the history of the international drug control regime and implications for future policymaking.
Subst Use Misuse
; 47(8-9): 923-35, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22676563
4.
Research as due diligence: What can supply-side interventions accomplish and at what cost?
Int J Drug Policy
; 41: 162-163, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28257908
5.
Assessing the harms of cannabis cultivation in Belgium.
Int J Drug Policy
; 26(3): 277-89, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25599596
6.
Better data, better policy and better lives: a call for improved drug monitoring and concerted responses.
Addiction
; 115(2): 199-200, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31353676
7.
If supply-oriented drug policy is broken, can harm reduction help fix it? Melding disciplines and methods to advance international drug-control policy.
Int J Drug Policy
; 23(1): 6-15, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21689918
8.
The global diversion of pharmaceutical drugs. India: the third largest illicit opium producer?
Addiction
; 104(3): 347-54, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19207342
9.
What does it mean to decriminalize marijuana? A cross-national empirical examination.
Adv Health Econ Health Serv Res
; 16: 347-69, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-17867248